Parexel, a global clinical research organization (CRO), has appointed Rob Goodwin as Chief Operating Officer (COO). In his new role, Goodwin will report to CEO Peyton Howell and be responsible for leading the core clinical functions, specifically, project management, clinical and data operations, inclusive of early phase clinical units, real world research, and the operational excellence office. “Rob’s deep industry experience and knowledge, biopharma relationships and proven, hands-on exp...